Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers

E-ISSN： 1875-5992|14|2|223-232

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.14, Iss.2, 2014-02, pp. : 223-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival of patients with blood-borne aids in Italy

By Bellocco R.

Journal of Epidemiology and Biostatistics, Vol. 5, Iss. 2, 2000-02 ,pp. : 79-87

Taylor & Francis Ltd

Access to resources Recommend Favorite

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma

By Lin Feng

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 649-653

Humana Press, Inc

Access to resources Recommend Favorite

Molecular Treatment of Different Breast Cancers

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 6, 2015-01 ,pp. : 701-720

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment

By Smalley Keiran SM Flaherty Keith T

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 775-778

Future Medicine

Access to resources Recommend Favorite

Second cancers in patients with brain tumours-impact of treatment

By Salminen E. Pukkala E. Teppo L.

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 102-105

Elsevier

Access to resources Recommend Favorite